Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET-Reference-Cited by-同舟云学术

Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET

Published:2013-04-10 Issue:5 Volume:78 Page:760-767
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Marotta Vincenzo¹,Ramundo Valeria¹,Camera Luigi²,Prete Michela Del¹,Fonti Rosa²,Esposito Raffaella¹,Palmieri Giovannella¹,Salvatore Marco²,Vitale Mario³,Colao Annamaria¹,Faggiano Antongiulio

Affiliation:

1. Department of Molecular and Clinical Endocrinology and Oncology; Federico II University of Naples; Napoli; Italy

2. Department of Biomorphological and Functional Sciences; Federico II University of Naples; Naples; Italy

3. Department of Medicine and Surgery; University of Salerno; Baronissi; Italy

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.12057/fullpdf

Reference39 articles.

1. Cancer statistics;Jemal;CA: A Cancer Journal for Clinicians,2010

2. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups;Yu;Thyroid,2010

3. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer;Cooper;Thyroid,2009

4. Papillary and follicular thyroid carcinoma;Schlumberger;New England Journal of Medicine,1998

5. Survival and death causes in differentiated thyroid carcinoma;Eustatia-Rutten;Journal of Clinical Endocrinology and Metabolism,2006

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Tyrosine Kinase Inhibitors in Downstaging and Palliation in Patients with Advanced Differentiated Thyroid Cancer — A Multicentre study;Indian Journal of Surgical Oncology;2024-08-09

2. Optimizing the indication of initial radioiodine oncolytic treatment for metastatic differentiated thyroid cancer by diagnostic 131I scan;Clinical Radiology;2024-07

3. Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer;Endocrine Practice;2024-05

4. Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life;The Journal of Clinical Endocrinology & Metabolism;2024-03-19

5. La PET/TC nell’era degli agenti citostatici: ruolo nella valutazione della risposta alla terapia con inibitori della tirosin-chinasi (TKI) nel carcinoma tiroideo;L'Endocrinologo;2024-01-03